US 9127021
Hepatitis C virus inhibitors
granted A61KA61K31/4188A61K31/422
Quick answer
US patent 9127021 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4188, A61K31/422, A61K31/427, A61K31/4439